Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

N/ACompletedNCT02678585

Assiut University106 enrolled

Overview

The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

106

Conditions

Postoperative Pain

Interventions

NalbuphineDRUG

53 patients received intravenous regional lidocaine plus nalbuphine

LidocaineDRUG

53 patients received intravenous regional lidocaine

Eligibility

Sex: ALLMin age: 20 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * adult patients * American Society of Anesthesiologists (ASA) physical status I-II * age between 20 and 50 years old * scheduled for elective unilateral short hand surgery Exclusion Criteria: * allergy to study medications * body mass index \> 35 kg/m2 * patients with sickle cell disease or Reynaud disease * patient refusal

Locations (1)

Assiut university hospital

Asyut, Egypt

Outcomes

Primary Outcomes

Tourniquet and postoperative pain measured by visual analogue scale

Time frame: 4 hours

Secondary Outcomes

Cortisol level

Time frame: 4 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.